Understanding and Tackling the Placebo Response in Parkinson's Disease
For indications like Parkinson’s disease (PD) that rely on subjective reporting measures, the placebo response is a major problem:
A problem that snowballs into higher development costs, longer timelines and the premature abandonment of development programs.
And, ultimately, a lack of cure for patients with PD.
In this guide, we discuss:
- How the placebo problem uniquely plays out in PD patients
- Historical approaches to managing the placebo response in PD
- A new strategy to work towards successfully delivering a cure